Newsletter 

Alzheimer's Disease - New Hope in the Horizon.

The U.S. FDA (Food and Drug Administration) approved 2 new drugs to treat early onset of Alzheimer’s Disease. 

This two treatments are anti-amyloid antibody intravenous infusion therapy for people with mild cognitive impairment or mild dementia due to Alzheimer's Disease. 

This drugs slow the decline of memory and thinking, as well as function. 

Aducanumab was approved on June 2021 Lecanemab was approved on January 2023. 

Alzheimer's Association - 12th Care Giver Conference

Ana Rickey, our Founder and Director, was honored to be invited to participate in the Alzheimer's Association 12th annual Caregiver's Journey conference in Providence, Rhode Island - US.

Ana represented Remember Me Dementia Care Education and shared important information about the Support Group for Alzheimer's and other Dementias that she is Mediator in Massachusetts - US.    

Did you know? - Dementia Care and Pet Therapy

Animal‐assisted therapy for dementia can help reduce the effects of dementia related behaviors such as anxiety, agitation, irritability, depression, and loneliness. 

Special trained animals and pets can help a dementia patient be more interactive, when sometimes they are not able to do so in social settings with other adults. 

Take the Path for Professional Dementia Certifications.

Remember Me offers two options of required Seminar in order to get certified by: 

NCCDP - National Council of Certified Dementia Practitioners as:
CDP - Certified Dementia Practitioner

ICCDP - International Council of Certified Dementia Practitioners as:
CMDCP Certified Montessori Dementia Care Professional 

To lean more about the Seminars: